Harrow, Inc. (HROW)
NASDAQ: HROW · Real-Time Price · USD
29.36
-1.16 (-3.80%)
At close: Oct 9, 2026, 4:00 PM EDT
29.90
+0.54 (1.84%)
After-hours: Oct 9, 2026, 7:30 PM EDT
Harrow Employees
Harrow had 373 employees as of December 31, 2025. The number of employees decreased by 9 or -2.36% compared to the previous year. That makes Harrow the 22,314th largest employer in the world and 2,911th in the United States.
Employees
373
Change (1Y)
-9
Growth (1Y)
-2.36%
Revenue / Employee
$738,858
Profits / Employee
-$99,802
Market Cap
1.10B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 373 | -9 | -2.36% | 373 | 0 |
| Dec 31, 2024 | 382 | 67 | 21.27% | 382 | 0 |
| Dec 31, 2023 | 315 | 98 | 45.16% | 315 | 0 |
| Dec 31, 2022 | 217 | 35 | 19.23% | 217 | 0 |
| Dec 31, 2021 | 182 | 57 | 45.60% | 182 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Perrigo Company | 8,100 |
| Trulieve Cannabis | 5,000 |
| Phibro Animal Health | 2,605 |
| Amphastar Pharmaceuticals | 1,976 |
| Alvotech | 1,279 |
| ANI Pharmaceuticals | 970 |
| Pacira BioSciences | 829 |
| Cronos Group | 610 |
HROW News
- 5 days ago - Harrow Closes Acquisition of TYRVAYA® - GlobeNewsWire
- 10 days ago - Harrow Ophthalmic Portfolio Highlighted in 15 Scientific Presentations at AAOpt and AAO - GlobeNewsWire
- 4 weeks ago - Harrow Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 4 weeks ago - Leerink bullish on Harrow, initiates with an Outperform - TheFly
- 4 weeks ago - Harrow initiated with an Outperform at Leerink - TheFly
- 5 weeks ago - Harrow to Participate in Three Investor Conferences in September - GlobeNewsWire
- 7 weeks ago - Harrow Announces IHEEZO® Data in Patient-Reported Discomfort Following Intravitreal Injections - GlobeNewsWire
- 2 months ago - Harrow Earnings Call Transcript: Q2 2026 - Transcripts